# Sandare Chemical Co., Inc.

- Location (FDA's records): Mchenry, IL
- FDA decisions: 23 (1979–1987): 23 510(k) clearances
- Product codes: LCP (4), JPK (2), CJR (1), CIC (1), JJX (1), CEO (1), CED (1), KRZ (1), JMO (1), CEK (1), CJW (1), JLC (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Recent decisions
- K872852: Eagle Diagnostics Glycohemoglobin Unitized Test (Sep 29, 1987)
- K862556: Sandare Glycohemoglobin Procedure (Aug 8, 1986)
- K860684: Sandare BCG Albumin Procedure (Mar 17, 1986)
- K851395: Sandare Iron-Binding Capacity Procedure (May 7, 1985)
- K851394: Sandare Iron Procedure (Apr 30, 1985)
- K844498: Sandare Alkaline Phosphatase Procedure (Dec 10, 1984)
- K842516: Sandare Acid Phosphatase Procedure (Aug 17, 1984)
- K833898: Tri-Level Bilirubin Controls (Jan 13, 1984)

Source page: https://510kreport.com/company/sandare-chemical